Comparison of Vasopressin and Other Pressors in Septic Shock

Sponsor
Université de Sherbrooke (Other)
Overall Status
Completed
CT.gov ID
NCT00269685
Collaborator
(none)
20

Study Details

Study Description

Brief Summary

The purpose of this study is to compare the classical tactics in the treatment of septic shock (dopamine, noradrenalin and dobutamine) to the use of vasopressin as first choice pressor.

Vasopressin seems to be an interesting alternative in the treatment of septic shock. To this date, available studies have showed that it could correct hyperkinetic syndrome and vasoplegia in septic shocks without noticeable side effect. It as been demonstrated that vasopressin improves renal function, as no effect on digestive organs and as no metabolic effect.

Condition or Disease Intervention/Treatment Phase
Phase 2/Phase 3

Study Design

Study Type:
Interventional
Allocation:
Randomized
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Comparative Prospective Study of Vasopressin and Catecholamine in Septic Shock
Study Start Date :
Jul 1, 2000

Outcome Measures

Primary Outcome Measures

  1. To compare the efficiency of vasopressine to the standard and usual treatment of septic shock on the reverse of the hemodynamic criterion of septic shock []

Secondary Outcome Measures

  1. To compare these two categories of treatment on: []

  2. tonometric parameters []

  3. renal function []

  4. in term of tolerance: metabolic effects (increase in lactate and glycaemia), cardiac effects (tachycardia being defined as a heart rate increase of 15%), increase of cardiac enzymes (troponine, CK, CK-MB), and cutanuous vasoconstriction. []

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Legally major patient presenting a septic shock.

The time window between beginning of symptoms and onset of treatment is established at 12 hours.

The patient must be intubated and mechanically ventilated.

Patient presenting a mean arterial blood pressure of less than 60 mm Hg after adequate fluid resuscitation (at least 1 L of colloid or crystalloid) and 10 ug/Kg/min of dopamine.

Patient presenting a cardiac index of at least 3 L/min/m2

Exclusion Criteria:
  • Shock other than septic

  • cardiac hypokinesia

  • a pre-existing organic renal failure that needs hemodyalisis

  • oesophagal or gastric phatology that would lead to a naso-gastric tube contraindication

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Université de Sherbrooke

Investigators

  • Principal Investigator: Olivier Lesur, Ph d, Centre de recherche du Centre hospitalier universitaire de Sherbrooke

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00269685
Other Study ID Numbers:
  • 00-33-R2
First Posted:
Dec 23, 2005
Last Update Posted:
May 29, 2006
Last Verified:
Aug 1, 2005

Study Results

No Results Posted as of May 29, 2006